TY  - JOUR
T1  - Slow Binding Deserves More Weight in Natural Product Lead Selection When Potency, Residence Time, and Functional Duration Tell Different Stories
A1  - Ana Rodrigues
A1  - Tiago Martins
A1  - Bruno Lopes
JF  - International Journal of Pharmaceutical And Phytopharmacological Research
JO  - Int J Pharm Phytopharmacol Res
SN  - 2250-1029
Y1  - 2025
VL  - 15
IS  - 4
DO  - 10.51847/5eEkiGuPXs
SP  - 94
EP  - 102
N2  - Natural-product lead selection is often dominated by equilibrium potency, even when candidates differ substantially in how rapidly they associate with a target, how slowly they dissociate, and how long their pharmacological effects persist after extracellular drug concentrations decline. This creates a ranking problem: a compound that appears weaker at a conventional endpoint may sustain target engagement or function longer than a nominally more potent comparator, whereas a long residence time may also fail to translate because of exposure limitations, rapid target turnover, weak rebinding, or cellular context. This article develops an original pharmacological framework for interpreting such discordance. The analysis separates equilibrium potency, association rate, dissociation rate, residence time, functional duration, rebinding, exposure, and target turnover rather than treating them as interchangeable indicators of binding strength. It argues that slow binding deserves additional lead-selection weight only when the kinetic difference is experimentally credible, survives functional testing, and remains pharmacologically meaningful in the relevant biological system. Natural-product examples illustrate why stereochemistry, macrocyclic architecture, conformational transitions, and multistate binding can generate kinetic behavior not captured by equilibrium potency alone. The proposed framework is therefore conditional rather than score based: kinetics can upgrade, downgrade, or leave unchanged a potency-led ranking depending on mechanistic and contextual evidence. The approach does not establish a universal residence-time threshold, prospective ranking accuracy, therapeutic superiority, or implementation readiness. Its purpose is to make kinetic evidence proportionate to what has actually been measured and to identify when discordant potency and duration warrant deeper mechanistic investigation.
UR  - https://eijppr.com/article/slow-binding-deserves-more-weight-in-natural-product-lead-selection-when-potency-residence-time-an-odicmnznwdsodgh
ER  -